Literature DB >> 28701356

Reciprocal regulation of miR-214 and PTEN by high glucose regulates renal glomerular mesangial and proximal tubular epithelial cell hypertrophy and matrix expansion.

Amit Bera1, Falguni Das1, Nandini Ghosh-Choudhury2,3, Meenalakshmi M Mariappan1, Balakuntalam S Kasinath1,2, Goutam Ghosh Choudhury4,2,5.   

Abstract

Aberrant expression of microRNAs (miRs) contributes to diabetic renal complications, including renal hypertrophy and matrix protein accumulation. Reduced expression of phosphatase and tensin homolog (PTEN) by hyperglycemia contributes to these processes. We considered involvement of miR in the downregulation of PTEN. In the renal cortex of type 1 diabetic mice, we detected increased expression of miR-214 in association with decreased levels of PTEN and enhanced Akt phosphorylation and fibronectin expression. Mesangial and proximal tubular epithelial cells exposed to high glucose showed augmented expression of miR-214. Mutagenesis studies using 3'-UTR of PTEN in a reporter construct revealed PTEN as a direct target of miR-214, which controls its expression in both of these cells. Overexpression of miR-214 decreased the levels of PTEN and increased Akt activity similar to high glucose and lead to phosphorylation of its substrates glycogen synthase kinase-3β, PRAS40, and tuberin. In contrast, quenching of miR-214 inhibited high-glucose-induced Akt activation and its substrate phosphorylation; these changes were reversed by small interfering RNAs against PTEN. Importantly, respective expression of miR-214 or anti-miR-214 increased or decreased the mammalian target of rapamycin complex 1 (mTORC1) activity induced by high glucose. Furthermore, mTORC1 activity was controlled by miR-214-targeted PTEN via Akt activation. In addition, neutralization of high-glucose-stimulated miR-214 expression significantly inhibited cell hypertrophy and expression of the matrix protein fibronectin. Finally, the anti-miR-214-induced inhibition of these processes was reversed by the expression of constitutively active Akt kinase and hyperactive mTORC1. These results uncover a significant role of miR-214 in the activation of mTORC1 that contributes to high-glucose-induced mesangial and proximal tubular cell hypertrophy and fibronectin expression.

Entities:  

Keywords:  cell hypertrophy and fibrosis; diabetic nephropathy; mTOR complex 1; microRNA

Mesh:

Substances:

Year:  2017        PMID: 28701356      PMCID: PMC5668576          DOI: 10.1152/ajpcell.00081.2017

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  97 in total

1.  High glucose down-regulates miR-29a to increase collagen IV production in HK-2 cells.

Authors:  Bin Du; Li-Ming Ma; Mian-Bo Huang; Hui Zhou; Hui-Lin Huang; Peng Shao; Yue-Qin Chen; Liang-Hu Qu
Journal:  FEBS Lett       Date:  2010-01-12       Impact factor: 4.124

2.  miR-21 and miR-214 are consistently modulated during renal injury in rodent models.

Authors:  Laura Denby; Vasudev Ramdas; Martin W McBride; Joe Wang; Hollie Robinson; John McClure; Wendy Crawford; Ruifang Lu; Dianne Z Hillyard; Raya Khanin; Reuven Agami; Anna F Dominiczak; Claire C Sharpe; Andrew H Baker
Journal:  Am J Pathol       Date:  2011-05-31       Impact factor: 4.307

3.  Unrestrained mammalian target of rapamycin complexes 1 and 2 increase expression of phosphatase and tensin homolog deleted on chromosome 10 to regulate phosphorylation of Akt kinase.

Authors:  Falguni Das; Nandini Ghosh-Choudhury; Nirmalya Dey; Chandi Charan Mandal; Lenin Mahimainathan; Balakuntalam S Kasinath; Hanna E Abboud; Goutam Ghosh Choudhury
Journal:  J Biol Chem       Date:  2011-12-19       Impact factor: 5.157

4.  Beyond secondary structure: primary-sequence determinants license pri-miRNA hairpins for processing.

Authors:  Vincent C Auyeung; Igor Ulitsky; Sean E McGeary; David P Bartel
Journal:  Cell       Date:  2013-02-14       Impact factor: 41.582

5.  The complex world of kidney microRNAs.

Authors:  Balakuntalam S Kasinath; Denis Feliers
Journal:  Kidney Int       Date:  2011-08       Impact factor: 10.612

6.  Structural basis for microRNA targeting.

Authors:  Nicole T Schirle; Jessica Sheu-Gruttadauria; Ian J MacRae
Journal:  Science       Date:  2014-10-31       Impact factor: 47.728

7.  Tuberin inhibits production of the matrix protein fibronectin in diabetes.

Authors:  Samy L Habib; Mukesh Yadav; Shaza Tizani; Basant Bhandari; Anthony J Valente
Journal:  J Am Soc Nephrol       Date:  2012-08-16       Impact factor: 10.121

Review 8.  Diabetic nephropathy: mechanisms of renal disease progression.

Authors:  Yashpal S Kanwar; Jun Wada; Lin Sun; Ping Xie; Elisabeth I Wallner; Sheldon Chen; Sumant Chugh; Farhad R Danesh
Journal:  Exp Biol Med (Maywood)       Date:  2008-01

9.  E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta.

Authors:  Bo Wang; Michal Herman-Edelstein; Philip Koh; Wendy Burns; Karin Jandeleit-Dahm; Anna Watson; Moin Saleem; Gregory J Goodall; Stephen M Twigg; Mark E Cooper; Phillip Kantharidis
Journal:  Diabetes       Date:  2010-04-14       Impact factor: 9.461

10.  ER stress negatively modulates the expression of the miR-199a/214 cluster to regulates tumor survival and progression in human hepatocellular cancer.

Authors:  Quanlu Duan; Xingxu Wang; Wei Gong; Li Ni; Chen Chen; Xingxing He; Fuqiong Chen; Lei Yang; Peihua Wang; Dao Wen Wang
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

View more
  23 in total

Review 1.  Identification of candidate microRNA biomarkers in diabetic nephropathy: a meta-analysis of profiling studies.

Authors:  Alieh Gholaminejad; Hossein Abdul Tehrani; Mohammad Gholami Fesharaki
Journal:  J Nephrol       Date:  2018-07-17       Impact factor: 3.902

2.  miR-214 represses mitofusin-2 to promote renal tubular apoptosis in ischemic acute kidney injury.

Authors:  Yu Yan; Zhengwei Ma; Jiefu Zhu; Mengru Zeng; Hong Liu; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2020-01-31

3.  Deacetylation of S6 kinase promotes high glucose-induced glomerular mesangial cell hypertrophy and matrix protein accumulation.

Authors:  Falguni Das; Soumya Maity; Nandini Ghosh-Choudhury; Balakuntalam S Kasinath; Goutam Ghosh Choudhury
Journal:  J Biol Chem       Date:  2019-04-26       Impact factor: 5.157

4.  Emerging role of miRNAs in renal fibrosis.

Authors:  Youling Fan; Hongtao Chen; Zhenxing Huang; Hong Zheng; Jun Zhou
Journal:  RNA Biol       Date:  2019-09-24       Impact factor: 4.652

5.  Viral delivery of multiple miRNAs promotes retinal ganglion cell survival and functional preservation after optic nerve crush injury.

Authors:  Ben Mead; Erin Cullather; Naoki Nakaya; Yuzhe Niu; Christo Kole; Zubair Ahmed; Stanislav Tomarev
Journal:  Exp Eye Res       Date:  2020-06-20       Impact factor: 3.467

Review 6.  Epigenetics in kidney diseases.

Authors:  Hao Ding; Lu Zhang; Qian Yang; Xiaoqin Zhang; Xiaogang Li
Journal:  Adv Clin Chem       Date:  2020-10-21       Impact factor: 6.303

7.  TGFβ acts through PDGFRβ to activate mTORC1 via the Akt/PRAS40 axis and causes glomerular mesangial cell hypertrophy and matrix protein expression.

Authors:  Soumya Maity; Falguni Das; Balakuntalam S Kasinath; Nandini Ghosh-Choudhury; Goutam Ghosh Choudhury
Journal:  J Biol Chem       Date:  2020-07-30       Impact factor: 5.157

8.  microRNA-181a downregulates deptor for TGFβ-induced glomerular mesangial cell hypertrophy and matrix protein expression.

Authors:  Soumya Maity; Amit Bera; Nandini Ghosh-Choudhury; Falguni Das; Balakuntalam S Kasinath; Goutam Ghosh Choudhury
Journal:  Exp Cell Res       Date:  2018-02-01       Impact factor: 3.905

9.  Dicer deficiency in proximal tubules exacerbates renal injury and tubulointerstitial fibrosis and upregulates Smad2/3.

Authors:  Zhengwei Ma; Qingqing Wei; Ming Zhang; Jian-Kang Chen; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2018-10-03

10.  p53/microRNA-214/ULK1 axis impairs renal tubular autophagy in diabetic kidney disease.

Authors:  Zhengwei Ma; Lin Li; Man J Livingston; Dongshan Zhang; Qingsheng Mi; Ming Zhang; Han-Fei Ding; Yuqing Huo; Changlin Mei; Zheng Dong
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.